Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	403,153 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	134,384 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	19,022,727 L.L
B01AC06	ASPIPHAR	G	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	134,384 L.L
C09AA01	APO-CAPTO	G	Captopril - 50mg	50mg	Tablet, scored	1,752,371 L.L
D06AX01	ACIDE FUSIDIQUE BGR	G	Fusidic acid - 2%	2%	Cream	202,920 L.L
L01XG01	ALVOCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	14,169,600 L.L
M05BA04	APO-ALENDRONATE	G	Alendronate (monosodium trihydrate) - 70mg	70mg	Tablet	981,005 L.L
R05CB01	ACC LONG	G	N-acetylcysteine - 600mg, Vitamin C - 75mg	600mg	Tablet, effervescent	286,238 L.L
N07CA01	ALVIGO	G	Betahistine dihydrochloride - 16mg	16mg	Tablet, scored	1,204,339 L.L
D06AX09	AVALON AVOBAN	G	Mupirocin - 2% w/w	2%	Ointment	460,938 L.L
C09AA05	ACURIL	G	Ramipril - 2.5mg	2.5mg	Tablet	497,222 L.L
N05AX12	ABIPREX 10	G	Aripiprazole - 10mg	10mg	Tablet	1,075,074 L.L
C09AA05	APO-RAMIPRIL	G	Ramipril - 2.5mg	2.5mg	Capsule	463,626 L.L
J05AF10	AVIRAVIR	G	Entecavir monohydrate - 1mg	1mg	Tablet, film coated	32,224,230 L.L
M05BA06	ADROMUX	G	Ibandronic acid - 150mg	150mg	Tablet, coated	821,088 L.L
N05AX12	ATYPRAL	G	Aripiprazole - 10mg	10mg	Tablet	712,237 L.L
R05CB06	API-MUCOL	G	Ambroxol HCl - 15mg/5ml	15mg/5ml	Syrup	326,554 L.L
A04AD12	APREPITANT BIOGARAN	G	Aprepitant - 80mg	80mg	Capsule	2,164,930 L.L
C09AA05	ACURIL	G	Ramipril - 5mg	5mg	Tablet	614,136 L.L
C10AA02	ATERKEY	G	Lovastatin - 20mg	20mg	Tablet	1,053,573 L.L
J01CA01	AMPICILLIN	G	Ampicillin (trihydrate) - 125mg/5ml	125mg/5ml	Powder for suspension	174,060 L.L
A04AD12	APREPITANT BIOGARAN 125MG APREPITANT BIOGARAN 80MG	G	Aprepitant - 125mg, Aprepitant - 80mg	125mg	Capsule	3,246,723 L.L
C09AA05	APO-RAMIPRIL	G	Ramipril - 5mg	5mg	Capsule	794,211 L.L
C10AA03	APO-PRAVASTATIN	G	Pravastatin Sodium - 40mg	40mg	Tablet	958,160 L.L
J01CA01	ANTALPEN	G	Ampicillin (trihydrate) - 125mg/5ml	125mg/5ml	Powder for suspension	174,060 L.L
J05AF10	APO-ENTECAVIR	G	Entecavir - 0.5mg	0.5mg	Tablet	28,943,287 L.L
J01CA01	AMPICILLIN	G	Ampicillin (trihydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	206,056 L.L

...